This post may contain affiliate links which may compensate us based on your interaction. Please read the disclosures for more information.
Wonder how a Trump or a Kamala presidency could affect the pharmaceutical industry? Muhammad Alimaki / Shutterstock.com
Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and divisive contest: It’s up to the government to cut high U.S. drug prices. Harris cast the tie-breaking Senate vote in 2022 for legislation that allows Medicare to negotiate drug prices for its more than 60 million beneficiaries. Before that, she was an aggressive regulator…